Prospeo
Hero Section BackgroundHero Section Background

CELOX First Aid for Bleeding Revenue

General ManufacturingFlag of USTonawanda, New York, United States1-10 Employees

$

CELOX First Aid for Bleeding revenue & valuation

Annual revenue$171,110
Revenue per employee$86,000
Estimated valuation?$547,552
Total fundingNo funding

Key Contact at CELOX First Aid for Bleeding

Flag of US

Bob Fudella

Vice President

Company overview

HeadquartersTonawanda, New York, United States
Website
NAICS312
Keywords
Sales, Ecommerce, Marketing, Logistics
Founded2009
Employees1-10
Socials

About CELOX First Aid for Bleeding

CELOX - Fast First Aid for Bleeding Whether it’s bleeding from a nosebleed, minor bleeding caused by a cut or scrape, a moderate bleeding emergency or a serious, life-threatening arterial injury: Bleeding Stops with CELOX. CELOX is the only product proven to stop bleeding in people who take anti-coagulant blood thinning medications like Coumadin, Warfarin and Heparin – some 35 million people in the U.S. alone. CELOX First Aid products are FDA and Health Canada cleared for consumer use to stop nosebleeds and minor, moderate and even severe arterial bleeding. CELOX is NOT A PHARMACEUTICAL: It is classified as a medical device, the same classification as an ordinary toothbrush. Celox products are safe, effective and easy to use: * By those with no emergency or medical training * For Plavix users * For those with bleeding disorders like Hemophilia & von Willebrand disease * For men, women, children and seniors CELOX also stops bleeding in hypothermic [cold] conditions -- a key benefit to those who ski, skate, hunt, play hockey or work outdoors. CELOX is currently marketed directly to consumers in the U.S. and Canada at www.celoxsales.com.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

CELOX First Aid for Bleeding has never raised funding before.

Frequently asked questions

CELOX First Aid for Bleeding is located in Tonawanda, New York, US.
CELOX First Aid for Bleeding generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
CELOX First Aid for Bleeding has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
CELOX First Aid for Bleeding was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.
CELOX First Aid for Bleeding has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles